AMG 337

Generic Name: AMG 337
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20101132Advanced Solid Tumors1A Phase 1, First-in-human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 337 in Adult Subjects With Advanced Solid Tumors
20120370MET Amplified Gastric (G), Gastroesophageal Junction (GEJ), or Esophageal (E) Adenocarcinoma or Other MET Amplified Solid Tumors1/2A Multicenter, Phase 1/2, Open-label Study Evaluating the Tolerability, Safety, Pharmacokinetics, and Efficacy of AMG 337 in Asian Subjects
20130111MET Amplified Gastric (G), Gastroesophageal Junction (GEJ), or Esophageal(E) Adenocarcinoma or Other MET Amplified Solid Tumors2A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG 337 in Subjects with MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors